ELISA Kit for Vimentin (VIM)

Specificity

This assay has high sensitivity and excellent specificity for detection of Vimentin (VIM).
No significant cross-reactivity or interference between Vimentin (VIM) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Vimentin (VIM) and the recovery rates were calculated by comparing the measured value to the expected amount of Vimentin (VIM) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 95-105 98
EDTA plasma(n=5) 80-99 89
heparin plasma(n=5) 81-102 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Vimentin (VIM) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Vimentin (VIM) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Vimentin (VIM) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-96% 89-103% 83-90% 80-90%
EDTA plasma(n=5) 83-105% 91-101% 80-98% 80-104%
heparin plasma(n=5) 82-89% 85-94% 79-101% 90-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Cancer Epidemiology, Biomarkers & Prevention Aberrant Vimentin Methylation Is Characteristic of Breast Cancer pubmed:22315367
Scientific Reports Glyoxalase 1-knockdown in human aortic endothelial cells - effect on the proteome andendothelial function estimates. pubmed:27898103
Journal of Proteomics HtrA3 is a cellular partner of cytoskeleton proteins and TCP1α chaperonin Pubmed:29477555
Journal of Biological Chemistry Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy Pubmed: 31511328
American Journal of Transplantation Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts Pubmed: 31729155
Lung Is Vimentin the Cause or Effect of Obstructive Sleep Apnea Development? Pubmed: 32088750
Cell Biol Toxicol ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer 33566221
CELL BIOLOGY AND TOXICOLOGY Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence 33758996
Comparison of Vimentin Levels Between Preeclamptic and Normotensive Pregnant Women
Advanced glycation end-products associate with podocytopathy in type II diabetic patients
Non-POU Domain-Containing Octamer-Binding (NONO) Protein Stability Regulated by PIN1 is Crucial for Breast Cancer Tumorigenicity Via the MAPK/β …
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPB040Mu02 Recombinant Vimentin (VIM) Positive Control; Immunogen; SDS-PAGE; WB.
RPB040Mu01 Recombinant Vimentin (VIM) Positive Control; Immunogen; SDS-PAGE; WB.
PAB040Mu02 Polyclonal Antibody to Vimentin (VIM) WB; IHC; ICC; IP.
PAB040Mu01 Polyclonal Antibody to Vimentin (VIM) WB; IHC; ICC; IP.
SEB040Mu ELISA Kit for Vimentin (VIM) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB040Mu Multiplex Assay Kit for Vimentin (VIM) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.